Skip to Main Content

Paper Details

Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes.
J Clin Lipidol
0
2022
ACS, MACE, acute coronary syndrome, acute coronary syndromes, alirocumab, atherosclerotic conditions, cardiovascular disease, cholesterol, diabetes, high-sensitivity C-reactive protein, hypertension, low-density lipoprotein cholesterol, patients, red blood cell, statin
Author NameAffiliation
Robert A HarringtonStanford Center for Clinical Research, Stanford University
Deepak L BhattBrigham and Women's Hospital Heart & Vascular Center and Harvard Medical School
  • 1 - 2

Datasets

Release 1.2